Kiora Pharmaceuticals, Inc.
KPRX
$2.55
-$0.04-1.54%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 62.89% | -24,415.30% | 101.25% | 1.85% | 48.08% |
| Total Depreciation and Amortization | -65.49% | 218.59% | 21.27% | 60.71% | 12.64% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -93.91% | 420.55% | -465.34% | -2.45% | 367.31% |
| Change in Net Operating Assets | -200.31% | -507.13% | 104.20% | -122.69% | -144.25% |
| Cash from Operations | -44.98% | -71.27% | 66.53% | -40.65% | -20.06% |
| Capital Expenditure | 93.61% | -19,450.00% | 98.76% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -0.39% | -5.46% | 724.38% | -73.94% | 510.65% |
| Cash from Investing | 0.97% | -6.82% | 764.29% | -75.15% | 453.72% |
| Total Debt Issued | -- | -100.00% | 75.00% | -- | -- |
| Total Debt Repaid | -- | 100.00% | -75.00% | -- | -- |
| Issuance of Common Stock | -33.33% | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -366.67% | -- | -100.00% | -- | -- |
| Foreign Exchange rate Adjustments | 6.91% | 42.42% | -89.97% | 1,202.97% | 113.38% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -29.14% | -28.86% | 263.39% | -12,774.65% | 98.85% |